Mim Neurosciences AB

Mim Neurosciences AB is a pioneering biotechnology research company dedicated to developing innovative treatments for neurodegenerative diseases. Focused on advancing NAD biology, Mim Neurosciences AB is committed to finding solutions that can significantly improve patient outcomes. The company's headquarters are located in Solna, Sweden, at the following address: c/o Pete Williams, Plan 6, S:t Eriks Ögonsjukhus, Solna, SE. Mim Neurosciences AB is dedicated to pushing the boundaries of biotechnology and improving the lives of individuals affected by neurodegenerative conditions.

Mim Neurosciences AB operates with a commitment to excellence in biotechnology research. The company's research and development efforts are geared towards creating therapies that address the underlying mechanisms of neurodegenerative diseases. By focusing on NAD biology, Mim Neurosciences AB aims to develop treatments that can halt or slow the progression of these debilitating conditions.

Mim Neurosciences AB is poised to make a substantial impact in the field of neurodegenerative disease treatment. The company’s innovative approach and dedication to scientific rigor position it as a key player in the biotechnology industry. We invite the manager of Mim Neurosciences AB to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and commercial development.